Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Novel Non-Invasive Liver Fibrosis Tests Are Effective Biopsy Alternatives
February 2026
Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.
Read more
9
Mins
31 May 2016
Immunopathogenesis of Hepatitis B Virus Infection and Related Complications
Chronic hepatitis B (CHB) is a serious consequence of hepatitis B virus (HBV), which infects and replicates in the liver.
9
Mins
31 May 2016
Manifestation of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Different Dietary Mouse Models
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which are usually associated with obesity and metabolic syndrome, are…
9
Mins
31 May 2016
Non-Malignant Portal Vein Thrombosis in Liver Cirrhosis: Diagnosis and Treatment
Portal vein thrombosis (PVT) is considered a common complication of liver cirrhosis. Its prevalence increases with liver disease severity, reaching 25%…
15 Apr 2016
UK Study Shows Rifaximin-α Significantly Reduces Hospital Resource Use for Patients with Hepatic Encephalopathy
LONDON, UK, Thursday 14 April, 07:00 BST: Norgine B.V. presented new positive UK real world practice data from the IMPRESS retrospective observational…
5 Apr 2016
Treatment Opportunities for Colorectal Liver Metastases
Colorectal liver metastases (CLM) are the most common hepatic malignancy and are caused by disseminated tumour cells (DTCs) seeded early in the…
5 Apr 2016
Alcoholic Liver Disease: A Comprehensive Review
Alcoholic liver disease, a leading cause of morbidity, mortality, and cirrhosis, can range from simple steatosis to hepatocellular carcinoma.
5 Apr 2016
Non-Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure
An alarming rise of obesity and, along with it, non-alcoholic fatty liver disease (NAFLD), has been observed in the USA and the rest of the world.
29 Mar 2016
Hepatitis C Provides Potent Antiviral Molecules
RESISTANT viruses may soon face a potent new antiviral body in the form of the amphipathic α-helical (AH) peptide, a molecule found within the hepatitis…
Loading posts...
« Previous
1
…
67
68
69
70
71
…
76
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View